June 4, 2018

IMBRUVICA (ibrutinib) in Combination With Rituximab for Waldenstrom’s Macroglobulinemia

Meletios Dimopoulos, MD, discusses his findings at the ASCO 2018 meeting in Chicago.

Meletios Dimopoulos, MD, discusses his findings at the ASCO 2018 meeting in Chicago.

Topics:

ASCO 2018 Hematologic Cancers

Next post in ASCO 2018

Management of malignant pleural effusions should be tailored to the particular patient, depending on

KEYNOTE-042: Pembrolizumab Improved Overall Survival in Non-Small Cell Lung Cancer